Medical Market Report

Global Bioresorbable Scaffolds Market By Type (Metallic Bioresorbable Scaffolds, and Polymer Bioresorbable Scaffolds), By Application (Coronary Artery Disease, Coronary Artery Bypass Grafting (CABG), and Peripheral Arterial Disease), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138055
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Bioresorbable Scaffolds Market is estimated to be valued US$ XX.X million in 2019. The report on Bioresorbable Scaffolds Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global bioresorbable scaffolds market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Bioresorbable Scaffolds Market Scope:

    By type, the market is segmented into Metallic Bioresorbable Scaffolds, and Polymer Bioresorbable Scaffolds. By Application, the market is divided into Coronary Artery Disease, Coronary Artery Bypass Grafting (CABG), and Peripheral Arterial Disease.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Abbott Laboratories, Amaranth Medical, Arterial Remodeling Technologies, BIOTRONIK, Elixir Medical, Kyoto Medical Planning, and Xenogenics Corporation.

    Key Market Segments

    Type

    Metallic Bioresorbable Scaffolds

    Polymer Bioresorbable Scaffolds

    Application

    Coronary Artery Disease

    Coronary Artery Bypass Grafting (CABG)

    Peripheral Arterial Disease

    Key Market Players included in the report:

    Abbott Laboratories

    Amaranth Medical

    Arterial Remodeling Technologies

    BIOTRONIK

    Elixir Medical

    Kyoto Medical Planning

    Xenogenics Corporation

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Bioresorbable Scaffolds Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Bioresorbable Scaffolds Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Bioresorbable Scaffolds Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Bioresorbable Scaffolds Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Bioresorbable Scaffolds Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Bioresorbable Scaffolds Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Bioresorbable Scaffolds sub-markets, depending on key regions (various vital states).
    To analyze Bioresorbable Scaffolds Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Bioresorbable Scaffolds Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Bioresorbable Scaffolds Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Bioresorbable Scaffolds Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Bioresorbable Scaffolds Market Overview
    

    3.1. Bioresorbable Scaffolds Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Bioresorbable Scaffolds Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Bioresorbable Scaffolds Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Metallic Bioresorbable Scaffolds
    

      4.4. Polymer Bioresorbable Scaffolds5. Global Bioresorbable Scaffolds Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Bioresorbable Scaffolds Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Coronary Artery Disease
    

      5.4. Coronary Artery Bypass Grafting (CABG)
    

      5.5. Peripheral Arterial Disease6. Global Bioresorbable Scaffolds Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Bioresorbable Scaffolds Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Bioresorbable Scaffolds Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Bioresorbable Scaffolds Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Bioresorbable Scaffolds Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Bioresorbable Scaffolds Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Bioresorbable Scaffolds Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Abbott Laboratories
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Amaranth Medical
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Arterial Remodeling Technologies
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. BIOTRONIK
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Elixir Medical
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Kyoto Medical Planning
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Xenogenics Corporation
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.